Quantitative Analysis of Pseudoephedrine Tablets by UHPLC-MS
The Application Notebook
An effective UHPLC-MS method for high throughput separation, identification and quantitation of pseudoephedrine was developed on a Hypersil GOLD™ PFP 1.9 µm, 2.1 x 100 mm column.
An effective UHPLC-MS method for high throughput separation, identification and quantitation of pseudoephedrine was developed on a Hypersil GOLD™ PFP 1.9 µm, 2.1 x 100 mm column.
Pseudoephedrine and ephedrine are highly coveted by drug traffickers who use them to manufacture methamphetamine, for the illicit market (1). The separation and identification of pseudoephedrine from illicit drug mixtures, especially the mathaphetamine group compounds, will help to identify the sources and the manufacture pathway of the methamphetamine seized in the illicit market.
We report separation, identification, and quantitation of pseudoephedrine in a mixture of five illicit drugs/metabolites by ultra high performance liquid chromatography-mass spectrometry (UHPLC-MS).
Results and Discussion
Pseudoephedrine was identified as the major active ingredient for all the three brand name drugs by UHPLC-MS method (Figure 1). The peak retention time of 2.62 min for all three samples matched very well with the retention time of the pseudoephedrine standard at 2.60 min. The confirmation of pseudoephedrine at 2.6 min was further assured by the match of the MS spectra of the three samples with the pseudoephedrine standard.
Figure 1
An internal standard method was used for the quantitative determination of pseudoephedrine in its tablet form. The concentration of the assay samples determined (120.09 ppb) were in good agreement with the reported values (120 ppb).
Conclusions
A simple, fast, and reliable separation and identification method for five drugs (pseudoephedrine, ephedrine, amphetamine, methamphetamine and 3,4-MDMA) using UHPLC-MS is developed. The ppb (ng/mL) level sensitivity and accuracy by this method are more than sufficient to identify and quantify pseudoephedrine and/or other components in the seized illicit drug samples.
References
(1) Pseudoephedrine Notice, Office of Division Control, US Department of Justice, Drug Enforcement Administration.
Thermo Fisher Scientific Inc.
355 River Oaks Parkway, San Jose, CA 95134-1991
tel. +1 800-532-4752; fax +1 561-688-8731
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
GPCRs – The Biological Traffic Modulator: Chromatographic Analysis of Peptides in the GI Tract
January 20th 2025The G protein-coupled receptors (GPCR) are found throughout the entire body and have shown significance in the development of new therapeutic treatments. Isolation of seven classic GRPC peptides initiating in the GI tract highlights the benefits of using the polymer-based PRP-3, a reversed-phase resin. The covalent bonds found in the PRP-3 exhibit advantageous interactions between the biological π bonds found in the peptides and the available aromatic benzyl rings of the resin.
